{
    "eid": "2-s2.0-85143869028",
    "title": "Implications of the antiviral drug favipiravir on rabies immunoglobulin for post-exposure prophylaxis of rabies in mice model with category III-like exposures",
    "cover-date": "2023-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Virology",
            "@code": "2406",
            "@abbrev": "IMMU"
        }
    ],
    "keywords": [
        "Category III exposure",
        "Favipiravir",
        "Post-exposure prophylaxis",
        "Rabies immunoglobulin",
        "Rabies virus"
    ],
    "authors": [
        "Kazunori Kimitsuki",
        "Sakirul Khan",
        "Ryo Kaimori",
        "Takaaki Yahiro",
        "Nobuo Saito",
        "Kentaro Yamada",
        "Nozomi Nakajima",
        "Takashi Komeno",
        "Yosuke Furuta",
        "Beatriz P. Quiambao",
        "Phatthamon Virojanapirom",
        "Thiravat Hemachudha",
        "Akira Nishizono"
    ],
    "citedby-count": 1,
    "ref-count": 35,
    "ref-list": [
        "Effects of homologous or heterologous antiserum on neutralizing-antibody response to rabies vaccine",
        "Passive immunity in the prevention of rabies",
        "Experimental treatment with favipiravir for COVID-19: an open-label control study",
        "In vivo efficacy of SYN023, an anti-rabies monoclonal antibody cocktail, in post-exposure prophylaxis animal models",
        "Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial, medRxiv",
        "Socioeconomic status is a critical risk factor for human rabies post-exposure prophylaxis",
        "Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase",
        "Mechanism of action of T-705 against influenza virus",
        "Rabies virus hijacks and accelerates the p75NTR retrograde axonal transport machinery",
        "Demographics of animal bite victims & management practices in a tertiary care institute in Mumbai, Maharashtra, India",
        "Global alliance for rabies control partners for rabies prevention",
        "Human rabies: neuropathogenesis, diagnosis, and management",
        "A country classification system to inform rabies prevention guidelines and regulations",
        "Near-infrared fluorescent protein iRFP720 is optimal for in vivo fluorescence imaging of rabies virus infection",
        "Role of favipiravir in the treatment of COVID-19",
        "Real-world experience with favipiravir for the treatment of mild-to-moderate COVID-19 in India",
        "Prospective immunogenicity study of multiple intradermal injections of rabies vaccine in an effort to obtain an early immune response without the use of immunoglobulin",
        "Pathological lesions in the central nervous system and peripheral tissues of ddY mice with street rabies virus (1088 strain)",
        "Evaluation of an improved rapid neutralizing antibody detection test (RAPINA) for qualitative and semiquantitative detection of rabies neutralizing antibody in humans and dogs",
        "The cellular immune response to rabies vaccination: a systematic review",
        "Favipiravir, an anti-influenza drug against life-threatening RNA virus infections",
        "A rapid reproducible test for determining rabies neutralizing antibody",
        "Recent advances in the development of monoclonal antibodies for rabies post exposure prophylaxis: a review of the current status of the clinical development pipeline",
        "Overview of Rabies Post-exposure Prophylaxis Access, Procurement and Distribution in Selected Countries in Asia and Africa, 2017\u20132018. Vaccine",
        "T-705 as a potential therapeutic agent for rabies",
        "Current rabies vaccines and prophylaxis schedules: preventing rabies before and after exposure",
        "Humoral immune responses after rabies infection",
        "Postexposure treatment of rabies infection: can it be done without immunoglobulin?",
        "Rabies vaccines: WHO position paper \u2013 april 2018 Introduction",
        "In vivo bioluminescent imaging of rabies virus infection and evaluation of antiviral drug",
        "Reevaluation of the efficacy of favipiravir against rabies virus using in vivo imaging analysis",
        "Efficacy of favipiravir (T-705) in rabies postexposure prophylaxis",
        "Efficacy of ormutivimab, a novel recombinant human anti-rabies monoclonal antibody, in post-exposure prophylaxis animal models"
    ],
    "affiliation": [
        {
            "affiliation-city": "Manila",
            "@id": "60071446",
            "affilname": "Gokila",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071446",
            "affiliation-country": "Philippines"
        },
        {
            "affiliation-city": "Oita",
            "@id": "60031051",
            "affilname": "Oita University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031051",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Yufu",
            "@id": "60030251",
            "affilname": "Oita University Faculty of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60030251",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Tokyo",
            "@id": "60016681",
            "affilname": "FUJIFILM Toyama Chemical Co., Ltd.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016681",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Miyazaki",
            "@id": "60001580",
            "affilname": "University of Miyazaki",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60001580",
            "affiliation-country": "Japan"
        }
    ],
    "funding": [
        "FUJIFILM Toyama Chemical Co."
    ]
}